Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

July 31, 2026

Study Completion Date

November 11, 2026

Conditions

Chronic Kidney Diseases

Interventions

DRUG

Colchicine

DRUG

Placebo

Trial Locations (1)

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Brigham and Women's Hospital

OTHER